Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07315334
Eligibility Criteria:
Inclusion Criteria:
\- Male and female patients with CIPN grade ≥ 2, according to Common Terminology Criteria for Adverse Events for peripheral sensory or motor neuropathy (CTCAE) version 5
\- Age ≥ 18
\- Ongoing or completed neuropathy-inducing chemotherapy
\- Ability to stand and walk
\- Ability to fill out a questionnaire Inclusion criteria for healthy controls
\- Male and female adults (age ≥ 18)
\- Ability to stand and walk
\- Ability to fill out a questionnaire
Exclusion Criteria:
* Pre-existing clinically manifest peripheral neuropathy prior to start of chemotherapy (e.g. caused by radiation or malignant plexopathy, lumbar or cervical radiculopathy, carpal tunnel syndrome, B12 deficiency, AIDS, monoclonal gammopathy, diabetes, heavy metal poisoning amyloidosis, syphilis, hyperthyroidism or hypothyroidism, inherited neuropathy, etc.)
Acute or chronic injuries/ diseases of the musculoskeletal system affecting functional tests
\- Acute or chronic cardiovascular diseases affecting functional tests
\- Neurological disease affecting functional tests (for healthy controls)
\- Neurological disease other than CIPN affecting functional tests (for CIPN patients)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07315334
Study Brief:
Protocol Section:
NCT07315334